 |
MorphoSys AG
MOR
|
1.02 |
- |
2.43 % |
$ 254 M |
Germany |
 |
Arbutus Biopharma Corporation
ABUS
|
3.76 |
$ 4.79 |
- |
$ 795 M |
Canada |
 |
Aclaris Therapeutics
ACRS
|
3.4 |
$ 3.04 |
- |
$ 235 M |
USA |
 |
Aeglea BioTherapeutics
AGLE
|
6.71 |
- |
- |
$ 1.01 B |
USA |
 |
Alpine Immune Sciences
ALPN
|
2.67 |
- |
- |
$ 2.17 B |
USA |
 |
AlloVir
ALVR
|
22.6 |
- |
4.14 % |
$ 49.1 M |
USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
3.59 |
- |
- |
$ 40.3 B |
USA |
 |
Aptorum Group Limited
APM
|
3.71 |
$ 1.17 |
- |
$ 6.38 M |
China |
 |
Ampio Pharmaceuticals
AMPE
|
2.41 |
- |
-11.43 % |
$ 502 K |
USA |
 |
Applied Molecular Transport
AMTI
|
2.31 |
- |
- |
$ 10.1 M |
USA |
 |
Midatech Pharma plc
MTP
|
2.29 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
Ascendis Pharma A/S
ASND
|
0.918 |
$ 212.81 |
1.71 % |
$ 5 B |
Danmark |
 |
Aptevo Therapeutics
APVO
|
1.44 |
$ 0.93 |
- |
$ 257 K |
USA |
 |
Alterity Therapeutics Limited
ATHE
|
7.02 |
$ 3.1 |
0.16 % |
$ 7.46 B |
Australia |
 |
BioVie
BIVI
|
8.46 |
$ 1.27 |
- |
$ 1.88 M |
USA |
 |
Biophytis SA
BPTS
|
1.34 |
- |
-13.47 % |
$ 169 M |
France |
 |
Athersys
ATHX
|
2.38 |
- |
3.77 % |
$ 22.4 M |
USA |
 |
Институт стволовых клеток человека
ISKJ
|
1.04 |
- |
- |
- |
Russia |
 |
Avenue Therapeutics
ATXI
|
3.27 |
- |
-52.27 % |
$ 4.45 M |
USA |
 |
ARCA biopharma
ABIO
|
28.7 |
- |
1052.0 % |
$ 415 M |
USA |
 |
AVROBIO
AVRO
|
15.9 |
- |
1083.1 % |
$ 745 M |
USA |
 |
Acasti Pharma
ACST
|
13.4 |
- |
4.01 % |
$ 150 M |
Canada |
 |
Adaptimmune Therapeutics plc
ADAP
|
1.16 |
- |
-15.15 % |
$ 60.3 M |
Britain |
 |
BioDelivery Sciences International
BDSI
|
2.37 |
- |
-4.8 % |
$ 255 M |
USA |
 |
Albireo Pharma
ALBO
|
2.39 |
- |
-0.23 % |
$ 916 M |
USA |
 |
BioNTech SE
BNTX
|
7.22 |
$ 95.03 |
- |
$ 27.2 B |
Germany |
 |
Amphastar Pharmaceuticals
AMPH
|
1.87 |
$ 26.81 |
1.36 % |
$ 1.3 B |
USA |
 |
BeiGene, Ltd.
BGNE
|
2.29 |
- |
0.49 % |
$ 251 B |
Cayman-islands |
 |
Can-Fite BioPharma Ltd.
CANF
|
2.76 |
$ 0.18 |
3.03 % |
$ 392 M |
Israel |
 |
Anika Therapeutics
ANIK
|
14.4 |
$ 9.48 |
- |
$ 139 M |
USA |
 |
Bellicum Pharmaceuticals
BLCM
|
6.32 |
- |
-9.72 % |
$ 5.89 M |
USA |
 |
Berkeley Lights
BLI
|
2.69 |
- |
-7.31 % |
$ 87 M |
USA |
 |
bluebird bio
BLUE
|
1.46 |
- |
- |
$ 546 M |
USA |
 |
Arena Pharmaceuticals
ARNA
|
10.8 |
- |
-6.81 % |
$ 3.04 B |
USA |
 |
Acer Therapeutics
ACER
|
0.41 |
- |
2.71 % |
$ 14 M |
USA |
 |
Calithera Biosciences
CALA
|
4.13 |
- |
-10.95 % |
$ 876 K |
USA |
 |
Axon Enterprise
AXON
|
2.08 |
$ 591.15 |
- |
$ 44.8 B |
USA |
 |
Ayala Pharmaceuticals
AYLA
|
6.43 |
- |
- |
$ 7.46 M |
Israel |
 |
Aytu BioScience
AYTU
|
1.47 |
$ 2.53 |
-0.39 % |
$ 15.9 M |
USA |
 |
AstraZeneca PLC
AZN
|
1.65 |
$ 92.45 |
- |
$ 96.9 B |
Britain |
 |
Acorda Therapeutics
ACOR
|
1.61 |
- |
-24.86 % |
$ 820 K |
USA |
 |
Catalyst Biosciences
CBIO
|
3.06 |
$ 12.37 |
2.06 % |
$ 814 M |
USA |
 |
Brickell Biotech
BBI
|
5.28 |
- |
-5.38 % |
$ 6.06 M |
USA |
 |
Burford Capital Limited
BUR
|
2.14 |
$ 9.0 |
- |
$ 1.48 B |
Britain |
 |
Celldex Therapeutics
CLDX
|
17.5 |
$ 26.83 |
- |
$ 1.73 M |
USA |
 |
Cellectar Biosciences
CLRB
|
0.467 |
$ 2.76 |
- |
$ 33.7 M |
USA |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
0.612 |
$ 10.81 |
- |
$ 699 M |
USA |
 |
Biogen
BIIB
|
2.47 |
$ 176.33 |
- |
$ 25.7 B |
USA |
 |
Cerevel Therapeutics Holdings
CERE
|
2.18 |
- |
- |
$ 7.29 B |
USA |